Related Experiment Video
Updated: Aug 7, 2026

Implantation and Monitoring by PET/CT of an Orthotopic Model of Human Pleural Mesothelioma in Athymic Mice
Published on: December 21, 2019
Subarachnoid-pleural fistula as a complication of malignant pleural mesothelioma
Christoph M Heyer1, Anja Theile, Heike Weisser
1Institute of Diagnostic Radiology, Interventional Radiology and Nuclear Medicine, Ruhr-University of Bochum, Bochum, Germany.
Abstract:
We report a 62-year-old male patient with asbestos-related malignant pleural mesothelioma who developed recurrent pleural effusions after surgical resection of paravertebral tumour masses. Pleural effusions were drained on several occasions with the patient suffering severe headaches and vascular dysregulation. Cytological studies of the pleural fluid showed no evidence of inflammatory or malignant cells. The fluid was interpreted as seroma despite its unusual transparency until magnetic resonance imaging was suggestive of a subarachnoid-pleural fistula; its presence was confirmed when beta-trace protein--a specific marker for cerebrospinal fluid--was added to the standard laboratory testing of the pleural effusion. A subarachnoid-pleural fistula has to be included in the differential diagnosis of patients with recurrent pleural effusions after surgical debulkment of malignant pleural mesothelioma. The beta-trace protein may help to establish this diagnosis especially in cases where important therapeutic consequences may need to be drawn.
Insights
A patient with asbestos-related mesothelioma developed recurrent pleural effusions post-surgery. Diagnosis of a cerebrospinal fluid leak (subarachnoid-pleural fistula) was confirmed using beta-trace protein testing.
Area of Science:
- Thoracic Surgery
- Neurosurgery
- Oncology
Background:
- Malignant pleural mesothelioma is a serious asbestos-related cancer.
- Recurrent pleural effusions can complicate post-surgical management.
- Paravertebral tumor resection is a surgical option for mesothelioma.
Observation:
- A 62-year-old male patient experienced recurrent pleural effusions after surgery for malignant pleural mesothelioma.
- The patient presented with headaches and vascular dysregulation.
- Pleural fluid analysis initially suggested seroma, lacking inflammatory or malignant cells.
Findings:
- Magnetic resonance imaging suggested a subarachnoid-pleural fistula.
- Beta-trace protein, a cerebrospinal fluid marker, confirmed the fistula in pleural fluid.
- This diagnosis was made despite unusual transparency of the pleural effusion.
Implications:
- Subarachnoid-pleural fistula should be considered in differential diagnoses for post-surgical recurrent pleural effusions in mesothelioma patients.
- Beta-trace protein testing is a valuable tool for diagnosing this fistula.
- Accurate diagnosis has significant therapeutic consequences.
Related Concept Videos
Pleural Disorders: Types and Brief Description
Pleural Effusion II: Symptoms and Management
A pleural effusion is the abnormal collection of fluid between the parietal and visceral pleura layers of tissue that form the lining of the lungs and chest cavity. It can occur independently or due to surrounding parenchymal diseases, such as infection, malignancy, or inflammatory conditions.
Clinical Manifestations:
Pleura of the Lungs
Pleural Effusion I: Introduction
There are two main types of pleural effusion: transudative and exudative. They are differentiated using Light's criteria,...
Esophageal Perforation-I: Introduction
The location of esophageal perforation can vary, occurring anywhere along the esophagus.
Pneumothorax-II
Clinical Manifestations: